Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Frontiers in Oncology|November 12, 2019
KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple MyelomaSergiu Pasca, Ciprian Tomuleasa, Patric Teodorescu, et al.
Cell Cycle (Georgetown, Tex.)|December 17, 2005
HOXB4 inhibits cell growth in a dose-dependent manner and sensitizes cells towards extrinsic cuesElke Will, Daniel Speidel, Zheng Wang, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Serine auxotrophy is a targetable vulnerability driven by PSAT1 suppression in AMLIlias Sinanidis, Panagiotis Tsakiroglou, Benjamin Dubner, et al.
The Journal of Clinical Investigation|October 25, 2016
Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistanceSalvador Alonso, Daniela Hernandez, Yu-Ting Chang, et al.
The Journal of Biological Chemistry|June 7, 2019
The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous atRA clearanceGuo Zhong, Cathryn Hogarth, Jessica M Snyder, et al.
Leukemia & Lymphoma|March 28, 2022
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemiaBrandy Perkins, Margaret Showel, Laura Schoch, et al.
Signal Transduction and Targeted Therapy|August 13, 2024
Therapeutic advances of targeting receptor tyrosine kinases in cancerCiprian Tomuleasa, Adrian-Bogdan Tigu, Raluca Munteanu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 26, 2020
Knockout of Cyp26a1 and Cyp26b1 during postnatal life causes reduced lifespan, dermatitis, splenomegaly, and systemic inflammation in miceJessica M Snyder, Guo Zhong, Cathryn Hogarth, et al.
Pageof 10